scorecardresearch
Add as a preferred source on Google
Monday, February 2, 2026
TopicBiocon

Topic: Biocon

Serum Institute to double investment in Biocon’s unit to $300 million

Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.

CBI alleges bribery in Biocon injection clearance, company says ‘approvals legitimate’

In a statement Monday, Biocon Biologics spokesperson said the injection is approved in Europe & many other countries. CBI has booked joint drug controller, Biocon executives in the case.

Biocon partners SII to make vaccine, drug manufacturing accessible to developing nations

Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.

Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries

Biocon Biologics partnered with international organisations to enhance access to life-saving cancer drugs for patients, especially in Sub-Saharan and Asian regions.

Monitor efficacy of Itolizumab, not just safety, in Covid trials — expert panel tells Biocon

Govt's expert panel, that advises the apex drug regulator, has asked Biocon to submit a revised proposal for phase 4 trials of Itolizumab, which already has emergency use approval.

In Covid quarantine, Netflix, Amazon Prime were my constant companions: Kiran Mazumdar Shaw

I was expecting the infection to be mild and short-lived. My Covid-19 experience has matched these expectations and I hope that it allays the fear of the virus.

Biocon to give more data on Itolizumab to Covid task force after its rejection for treatment

The company said it would share more data as ‘evidence’, which it has derived from off-label use of the drug on 1,000 patients.

30 patients, 2 months — how Biocon claims to have found a Covid hope in itolizumab

The drug controller general of India (DCGI) had Saturday approved Biocon’s itolizumab for emergency, restricted use among severe Covid-19 patients.

All about Biocon’s Itolizumab, psoriasis drug approved for emergency use in Covid patients

DGCI has given 'restricted emergency use' approval to the drug for treating Covid-19 patients with moderate-to-severe acute respiratory distress.

India prepares to test Itolizumab, the drug credited for lowering Covid mortality in Cuba

The drug will go under trial in six hospitals in India, including AIIMS-Delhi, KEM Hospital in Mumbai and Narayana Health in Bengaluru. 

On Camera

India needs derivatives for high economic growth. STT hike is a bad move

A sound tax system is one based on the ability to pay or economic surplus. But the STT taxes the circulation of capital and not its returns, making it deeply distortionary.

Seafood industry welcomes Budget’s fisheries push. ‘Lays groundwork for becoming global player’

Exporters said the Budget’s proposals to increase duty-free import limits on processing, create 500 reservoirs and support fisheries startups will boost the marine industry.

More boots, bigger budget: Agnipath outlay jumps 58%, Army’s share the largest

With recruitments under Agnipath set to rise, the Union Budget has significantly increased spending, with the Army taking nearly 87% of the total outlay. 

Swiss report should now close Op Sindoor debate. Knowing when to stop the fight is key too

The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.